Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

By R. Childs, A. Chernoff, N. Contentin, E. Bahceci, D. Schrump, S. Leitman, E. Read, J. Tisdale, C. Dunbar, W. Linehan and 2 more. New England Journal of Medicine, 2000

991 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/36cd32d0f48c3723c5a2d3bbe91b3f8b5af1b499

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. S. Rosenberg
2. Jie Yang
3. R. Sherry
4. U. Kammula
5. M. Hughes
6. S. Topalian
7. N. Restifo
8. C. June

Citations in the corpus

• Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. (2001, background): “peripheral-blood stem-cell transplantation treatment (25) and by treatment by monoclonal antibodies (26).”
• Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. (2004, background): “One study showed that patients with metastatic RCC achieved complete response to allogeneic bone marrow transplantation [50], but a second study showed that this approach was highly patient selective and toxic [51].”
• Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. (2006, background): “Enterocolitis from graft-versus-host disease was significantly associated with the regression of RCC in patients treated with a miniallotransplant regimen.(20) A randomized study has suggested that a contributing factor to enterocolitis in this setting may be intestinal microflora and bacterial anti”